Published :
Tables : 64
Figures : 44
Category : Healthcare
No. of Pages : 215
Report Code : HC-U3146
Drug Screening Market is poised to value over USD 11.5 billion by 2027 end at a CAGR of over 9.2% during the forecast period 2020 to 2027 There has been a rise in the comsumption of unprescribed drugs and alcohol worldwide. As per the report published by the United Nations Office on Drugs and Crime (UNODC) 2015, over 5% of the global adult population has at least tried drugs once in their lifetime. Furthermore, over 0.6% of the total adult population across the world suffer from drug abuse disorder. Owing to these statictics, the drug screening market is esimated to showcase substantial growth over the forecasted timeframe. FutureWise Market Research has instantiated a report that provides an intricate analysis of Drug Screening Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of Drug Screening Market. According to the research study conducted by FutureWise research analysts, the Drug Screening Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Drug Screening Market are: Alere Dragerwerk Labcorp Quest Diagnostics Alfa Scientific Designs Lifeloc MPD Inc. Orasure Omega Laboratories Premier Biotech Psychemedics Roche Shimadzu Siemens Healthineers Thermo Fisher Scientific (Note: The list of the major players will be updated with the latest market scenario and trends) Drug Screening Market Segmentation: By Product • Analytical Instruments o Immunoassay Analyzers o Chromatography Instruments o Breathalyzers o Fuel Cell Breathalyzers o Semiconductor Breathalyzers o Other Breathalyzers • Rapid Testing Devices o Urine Testing Devices o Drug Testing Cups o DIP Cards o Drug Testing Cassettes o Oral Fluid Testing Devices • Consumables o Assay Kits o Sample Collection Devices o Calibrators and Controls o Other Consumables By Drug Screening Services Regulated Non-Regulated By Sample Type Urine Samples Breath Samples Oral Fluid Samples Hair Samples Other Samples By End-user Workplace Criminal Justice Systems and Law Enforcement Agencies Drug Treatment Centers Pain Management Centers Schools and Colleges Hospitals Individual Users Drug Testing Laboratories By Region North America Latin America Europe Asia-Pacific Rest of the world Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the Drug Screening Market By Product, By Drug Screening Services, By Sample Type, By End User and By Region. To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with the purchase of any license of the report You can directly share your requirements/changes to the current table of content to sales@futurewiseresearch.com
There has been a rise in the comsumption of unprescribed drugs and alcohol worldwide. As per the report published by the United Nations Office on Drugs and Crime (UNODC) 2015, over 5% of the global adult population has at least tried drugs once in their lifetime. Furthermore, over 0.6% of the total adult population across the world suffer from drug abuse disorder. Owing to these statictics, the drug screening market is esimated to showcase substantial growth over the forecasted timeframe.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Drug Screening Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of Drug Screening Market.
According to the research study conducted by FutureWise research analysts, the Drug Screening Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Drug Screening Market are:
(Note: The list of the major players will be updated with the latest market scenario and trends)
Drug Screening Market Segmentation:
By Product
• Analytical Instruments o Immunoassay Analyzers o Chromatography Instruments o Breathalyzers o Fuel Cell Breathalyzers o Semiconductor Breathalyzers o Other Breathalyzers • Rapid Testing Devices o Urine Testing Devices o Drug Testing Cups o DIP Cards o Drug Testing Cassettes o Oral Fluid Testing Devices • Consumables o Assay Kits o Sample Collection Devices o Calibrators and Controls o Other Consumables
By Drug Screening Services
By Sample Type
By End-user
By Region
Competitive Landscape:
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Drug Screening Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Medical Device Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Drug Screening Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Drug Screening Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Analytical Instruments 7.1.1. Immunoassay Analyzers 7.1.2. Chromatography Instruments 7.1.3. Breathalyzers 7.1.3.1. Fuel Cell Breathalyzers 7.1.3.2. Semiconductor Breathalyzers 7.1.3.3. Other Breathalyzers 7.2. Rapid Testing Devices 7.2.1. Urine Testing Devices 7.2.1.1. Drug Testing Cups 7.2.1.2. DIP Cards 7.2.1.3. Drug Testing Cassettes 7.2.2. Oral Fluid Testing Devices 7.3. Consumables 7.3.1. Assay Kits 7.3.2. Sample Collection Devices 7.3.3. Calibrators and Controls 7.3.4. Other Consumables 8. Global Drug Screening Market, By Drug Screening Services Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Regulated 8.2. Non-Regulated 9. Global Drug Screening Market, By Sample Type Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Urine Samples 9.2. Breath Samples 9.3. Oral Fluid Samples 9.4. Hair Samples 9.5. Other Samples 10. Global Drug Screening Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Workplace 10.2. Criminal Justice Systems and Law Enforcement Agencies 10.3. Drug Treatment Centers 10.4. Pain Management Centers 10.5. Schools and Colleges 10.6. Hospitals 10.7. Individual Users 10.8. Drug Testing Laboratories 11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2020-2027 13. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Regional Market Trends 13.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.3.1. Brazil 13.3.2. Venezuela 13.3.3. Argentina 13.3.4. Rest of Latin America 13.4. Market Size (USD Million) Forecast for Latin America 2020-2027 14. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Switzerland 14.2.9. Rest of Western Europe 14.3. Market Size (USD Million) Forecast for Europe 2020-2027 15. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Japan 15.2.2. China 15.2.3. Singapore 15.2.4. India 15.2.5. Australia and New Zealand 15.2.6. ASEAN 15.2.7. South Korea 15.2.8. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 16.2.1. Saudi Arabia 16.2.2. UAE 16.2.3. South Africa 16.2.4. Egypt 16.3. Market Size (USD Million) Forecast for MEA 2020-2027 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 17.1 ALERE 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2 DRAGERWERK 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3 LABCORP 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4 QUEST DIAGNOSTICS 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5 ALFA SCIENTIFIC DESIGNS 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6 LIFELOC 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7 MPD INC. 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8 ORASURE 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9 OMEGA LABORATORIES 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10 PREMIER BIOTECH 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11 PSYCHEMEDICS 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12 ROCHE 17.12.1. Company Overview 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview 17.13 SHIMADZU 17.13.1. Company Overview 17.13.2. Product Portfolio 17.13.3. SWOT Analysis 17.13.4. Financial Overview 17.13.5. Strategic Overview 17.14 SIEMENS HEALTHINEERS 17.14.1. Company Overview 17.14.2. Product Portfolio 17.14.3. SWOT Analysis 17.14.4. Financial Overview 17.14.5. Strategic Overview 17.15 THERMO FISHER SCIENTIFIC 17.15.1. Company Overview 17.15.2. Product Portfolio 17.15.3. SWOT Analysis 17.15.4. Financial Overview 17.15.5. Strategic Overview 18. FutureWise SME key takeaway points for Client
1. Market Introduction
1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders
2. Research Methodology
2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study
3. Executive Summary
3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights
4. Global Drug Screening Market Variables, Trends & Scope
4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview
5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Medical Device Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Drug Screening Market Analysis Tools
6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Global Drug Screening Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million)
7.1. Analytical Instruments 7.1.1. Immunoassay Analyzers 7.1.2. Chromatography Instruments 7.1.3. Breathalyzers 7.1.3.1. Fuel Cell Breathalyzers 7.1.3.2. Semiconductor Breathalyzers 7.1.3.3. Other Breathalyzers 7.2. Rapid Testing Devices 7.2.1. Urine Testing Devices 7.2.1.1. Drug Testing Cups 7.2.1.2. DIP Cards 7.2.1.3. Drug Testing Cassettes 7.2.2. Oral Fluid Testing Devices 7.3. Consumables 7.3.1. Assay Kits 7.3.2. Sample Collection Devices 7.3.3. Calibrators and Controls 7.3.4. Other Consumables
8. Global Drug Screening Market, By Drug Screening Services Historical Analysis and Forecast 2020-2027 (USD Million)
8.1. Regulated 8.2. Non-Regulated
9. Global Drug Screening Market, By Sample Type Historical Analysis and Forecast 2020-2027 (USD Million)
9.1. Urine Samples 9.2. Breath Samples 9.3. Oral Fluid Samples 9.4. Hair Samples 9.5. Other Samples
10. Global Drug Screening Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
10.1. Workplace 10.2. Criminal Justice Systems and Law Enforcement Agencies 10.3. Drug Treatment Centers 10.4. Pain Management Centers 10.5. Schools and Colleges 10.6. Hospitals 10.7. Individual Users 10.8. Drug Testing Laboratories 11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2020-2027
13. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
13.1. Introduction 13.2. Regional Market Trends 13.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.3.1. Brazil 13.3.2. Venezuela 13.3.3. Argentina 13.3.4. Rest of Latin America 13.4. Market Size (USD Million) Forecast for Latin America 2020-2027
14. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Switzerland 14.2.9. Rest of Western Europe 14.3. Market Size (USD Million) Forecast for Europe 2020-2027
15. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Japan 15.2.2. China 15.2.3. Singapore 15.2.4. India 15.2.5. Australia and New Zealand 15.2.6. ASEAN 15.2.7. South Korea 15.2.8. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 16.2.1. Saudi Arabia 16.2.2. UAE 16.2.3. South Africa 16.2.4. Egypt 16.3. Market Size (USD Million) Forecast for MEA 2020-2027
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
17.1 ALERE 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2 DRAGERWERK 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3 LABCORP 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4 QUEST DIAGNOSTICS 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5 ALFA SCIENTIFIC DESIGNS 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6 LIFELOC 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7 MPD INC. 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8 ORASURE 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9 OMEGA LABORATORIES 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10 PREMIER BIOTECH 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11 PSYCHEMEDICS 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12 ROCHE 17.12.1. Company Overview 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview 17.13 SHIMADZU 17.13.1. Company Overview 17.13.2. Product Portfolio 17.13.3. SWOT Analysis 17.13.4. Financial Overview 17.13.5. Strategic Overview 17.14 SIEMENS HEALTHINEERS 17.14.1. Company Overview 17.14.2. Product Portfolio 17.14.3. SWOT Analysis 17.14.4. Financial Overview 17.14.5. Strategic Overview 17.15 THERMO FISHER SCIENTIFIC 17.15.1. Company Overview 17.15.2. Product Portfolio 17.15.3. SWOT Analysis 17.15.4. Financial Overview 17.15.5. Strategic Overview
18. FutureWise SME key takeaway points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics